Tag Archives: PMCB

Pharmacyte Biotech Inc (OTCMKTS:PMCB) just reported that it’s the recipient of what’s called the Pipelines of Promise Award from BIO International. There are a few benefits associated with this award, including what looks like some...

Things are really starting to pick up pace at Pharmacyte Biotech Inc (OTCMKTS:PMCB). A look at the company’s share price doesn’t suggest as much, but operational developments do, and when markets shift to reflect what’s going...

Pharmacyte Biotech Inc (OTCMKTS:PMCB) is a company that we keep coming back to and it’s been a real winner over the last few months. Back at the end of November, the company traded for less than $0.05 a share. At the end of last year,...

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology...

Globally, the race is on for more effective treatments of diabetes. A new report by Visiongain predicts the world market for diabetes medications will reach $55.3B in 2017. The antidiabetic medicines industry generated $35.6B in 2012, and...

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter